Diet pills market in Europe: UK is expected to exceed a value of approx. US $ 193 million by 2031 End


250-page survey of the diet pills market in Europe by Fact MR, a leading provider of business and business intelligence

According to the recent Fact MR market research, sales of diet pills in Europe will increase at a propelled CAGR until 2031, as investments in health infrastructure expansion continue to increase. The aim of the survey is to uncover growth opportunities, key trends, growth drivers and challenges. It also provides recommendations to help businesses prepare for unforeseen challenges.

The focus on improving overall patient care will remain the main driver of growth. In addition to this, the European diet pill market will continue to benefit from the increasing willingness of patients and families to spend on advanced healthcare.

To stay ahead of your competition, request a sample –

Data recently published in Fact.MR’s market analysis shows that the demand for diet pills in Europe is expected to increase at a CAGR of 2.6% until 2031, the market being valued at US $ 669 million currently.

Sales of glucomannan drugs are expected to increase by US $ 258.1 million in 2020 around US $ 361.2 million by 2031, while those for herbal supplements $ 455.1 Mn about US $ 611.6 million.

Digital transformation in healthcare presents opportunities for the growth of the diet pills market in Europe

Healthcare organizations around the world are deploying digital tools to adapt to changing consumer preferences. They strive to solve the long-standing challenge of innovating models of care.

In view of this, the focus will be on affordable and more transparent healthcare. The adoption of the model of care innovation in healthcare will have a profound impact on the European diet pill market.

The market research carried out by Fact.MR provides exclusive insights into the growth of the market. The study identifies the crucial trends that are determining the growth of the diet pills market in Europe. This recently released report sheds light on vital dynamics, such as drivers, restraints, and opportunities for key market players as well as emerging players associated with production and supply. Latest Fact.MR Report Provides Detailed Analysis Of Europe Diet Pills Market

Need more information on the reporting methodology? Click here –

The report offers actionable and valuable insights into the Europe Diet Pills market. The latest report from Fact.MR provides details about the current market scenario across various regions along with historical data and market forecast. The report also includes information on sales and demand of the Europe Diet Pills market across various industries and regions.

This recently released and insightful report sheds light on the outlook for the Europe diet pills market, key dynamics, their impact on the overall value chain from vendors to end users, and the growth of the Europe diet pills market..

Segments Covered Europe Diet Pill Industry Research

Drug class

    • Lipase inhibitors
    • Choline
    • Glucomannan
    • Garcinia Cambogia
    • Others

Type of drug

    • Prescription drugs
    • Over-the-counter medications
    • Herbal supplements


    • Diet pills increasing metabolism
    • Diet pills blocking fat
    • Diet pills to control appetite
    • Others

· Distribution channel

    • Diet pills sold in hospital pharmacies
    • Diet pills sold in retail pharmacies
    • Diet pills sold in clinics
    • Online sale of diet pills (e-commerce)
    • Sales of diet pills by pharmacies

Full access to this exclusive report is available at

Europe Diet Pills Market – Scope of the Report

The latest publication by Fact.MR on the Europe Diet Pills Market assesses the opportunities and current market landscape, and provides detailed analysis and updates on the corresponding sections affecting the market. The study offers in-depth information on key market dynamics, which includes drivers, restraints, trends, and opportunities in the Europe Diet Pills market. The main objective of the market research is to present proprietary information on the performance of the market during the forecast period 2021-2031.

Significant indicators for the successful growth of the Diet Pills market in Europe are presented in this comprehensive report, which includes an analysis of the annual growth of the market and the compound annual growth rate (CAGR), which are comprehensively described in Study by Fact.MR. This research study may help readers to know the demand for diet pills in Europe and the opportunities for quantitative development during the study period.

The research is beneficial to market shareholders, including investors, manufacturers, service providers, distributors, and suppliers, who can help them develop appropriate business strategies to thrive in the market. The information and data analysis presented in this Fact.MR study can be leveraged by European diet pill market shareholders, industry experts, investors, researchers and journalists, as well as business enthusiasts.

The market statistics, along with information related to macro and microeconomic variables affecting the business scenario in the Europe Diet Pills market are also included in the present study. Depending on the potential developments in the market, substantial information is also encountered in this report. Additionally, with the data submitted in this report, small businesses and new entrants can be helped to make appropriate business choices to gain traction in the market.

Competitive landscape

The main players are focused on expanding into emerging countries and introducing features into their product lines. Various manufacturers are investing in the development of integrated software that may include advanced technologies to understand the formulation of diet pills.

Market players are also committed to expanding their regional presence through acquisitions, collaborations, expansions, product launches and improvements to distribution channels.

  • In September 2019, Currax Pharmaceuticals LLC announced the acquisition of Nalpropion Pharmaceuticals, Inc. Currax now owns the worldwide rights to CONTRAVE, which is the most prescribed brand-name weight loss drug.
  • In June 2020, Holland & Barrett and Deliveroo announced a new partnership to bring a select range of over 200 products in 50 stores across the UK.
  • In September 2018, Nature’s Way Products, LLC and Natural Products Canada entered into a new investment agreement to invest in new companies working in natural products sectors such as supplements and food ingredients.

Read more of Fact.MR’s trend reports-

Benefits of the report and answers to key questions

  • Category and Segment Level Analysis of Diet Pills in Europe: Fact MR provides a detailed analysis of the factors influencing sales growth in key segments. It highlights the main drivers of growth and provides useful information to identify sales prospects at regional and local level.
  • Europe Diet Pills Analysis of historical volumes: The report provides a comparison of historical Europe Diet Pills sales and projected sales performance for 2021-2031.
  • Europe Diet Pills Manufacturing Trend Analysis: The report offers a detailed analysis of manufacturing trends in the diet pills market in Europe. It carefully assesses the impact of changing healthcare needs of key demographics globally
  • Consumption of diet pills in Europe by demographics: The report studies consumer behavior affecting the demand outlook for diet pills in Europe for the assessment period. The effect of their interest in digital trends in the diet pill market in Europe is carefully analyzed
  • Post COVID consumer spending on diet pills in Europe: The health sector has been largely influenced by the COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending after COVID-19. It assesses how the current trends that will influence the expenditure on healthcare services, thereby affecting the growth of the diet pills market in Europe.

More valuable insight into the European diet pill market

Fact.MR in its new report offers an unbiased analysis of the Europe diet pills market, diet pills sales and demand in Europe, analyzing the forecast statistics to 2019 and beyond. The study reveals growth projections based on various criteria.

Explore Fact.MR’s comprehensive healthcare coverage:

Fluorinated Enzyme Assay Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs MarketGlobal Industry Analysis and Opportunity Assessment 2021-2031

Infrared Thermometers MarketGlobal Industry Analysis and Opportunity Assessment 2021-2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1000 companies trust us to make their most critical decisions. We have offices in the United States and Dublin, while our global headquarters are in Dubai. While our experienced consultants use the latest technology to extract hard-to-find information, we believe our USP is the trust clients have in our expertise. Covering a wide spectrum – from Automotive and Industry 4.0 to Healthcare and Retail, our coverage is broad, but we make sure that even the most specialized categories are analyzed. Contact us with your goals, and we will be a competent research partner.

US Sales Office:
11140 Rockville Pike
Office 400
Rockville, Maryland 20852
United States
Phone. : +1 (628) 251-1583
Email: [email protected]

The head office:
Unit number: AU-01-H Gold Tower (AU),
Plot number: JLT-PH1-I3A,
Jumeirah Lakes Tours,
Dubai, United Arab Emirates

The European diet pill market: UK is expected to exceed a value of approx. $ 193 million by 2031 The ending appeared first on the latest market reports.